Companies

Alltracel Pharmaceuticals

Overview

Dublin-based Alltracel Pharmaceuticals is involved in developing and supplying wound care, oral care (including dental floss, toothbrushes and breath fresheners), skin care and cardiovascular health treatments. Some of the wound care products are sold under the 'm.doc' name. It joined Aim in July 2001 at 89p a share. A Czech joint venture called Nanopeutics is developing Nanospider technology, which will enable nanofiber materials to be produced that could transform a number of healthcare sectors (according to the company).

Sector: Health

News blog

• Alltracel Pharmaceuticals Posted: 22/02/2008
• Alltracel Pharmaceuticals Posted: 21/01/2008
• Alltracel Pharmaceuticals Posted: 23/08/2007

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period